Literature DB >> 1899628

Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection.

J P Vendrell1, M Segondy, J Ducos, J Reynes, M F Huguet, J C Nicolas, A Serre.   

Abstract

We studied the spontaneous in vitro secretion of anti-HIV-1 antibodies by peripheral blood mononuclear cells (PBMC) from HIV-1-infected patients. Specific antibody production was detected in supernatants of PBMC cultures using an ELISA; HIV-1 specificity was confirmed by antigen adsorption and Western blotting. This antibody secretion was found to be an active phenomenon and was not due to a release of plasma antibodies passively adsorbed onto the cell membranes. In all positive supernatants, anti-HIV-1-secreted antibodies were directed against env-encoded antigens and many supernatants also contained antibodies to pol- and gag-encoded antigens. PBMC from all HIV-1-infected patients tested (140 adults and 18 infants) secreted anti-HIV-1 antibodies. This production was found during all the clinical stages of HIV-1 infection. Our results suggest that this spontaneous HIV-1-specific antibody secretion represents a marker of HIV-1 infection. Detection of these antibodies could be a valuable tool for early confirmation of HIV-1 infection in neonates born to HIV-1-seropositive mothers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899628      PMCID: PMC1535267          DOI: 10.1111/j.1365-2249.1991.tb05614.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection.

Authors:  D Gold; R Ashley; H H Handsfield; M Verdon; L Leach; J Mills; L Drew; L Corey
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction.

Authors:  F Laure; V Courgnaud; C Rouzioux; S Blanche; F Veber; M Burgard; C Jacomet; C Griscelli; C Brechot
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Immune response to acute diarrhea seen as circulating antibody-secreting cells.

Authors:  A M Kantele; R Takanen; H Arvilommi
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

4.  Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.

Authors:  S Pahwa; R Pahwa; R A Good; R C Gallo; C Saxinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  In-vitro secretion of HIV-specific antibodies by peripheral blood cells.

Authors:  J P Vendrell; J Reynes; H Rabesandratana; G Marguerite; P Corbeau; A Serre; M F Huguet; A Cannat
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

6.  Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro.

Authors:  M A Abbott; B J Poiesz; B C Byrne; S Kwok; J J Sninsky; G D Ehrlich
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus.

Authors:  S M Schnittman; H C Lane; S E Higgins; T Folks; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

8.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Authors:  R Yarchoan; R R Redfield; S Broder
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Serodiagnosis of toxoplasma infection using a purified parasite protein (P30).

Authors:  F Santoro; D Afchain; R Pierce; J Y Cesbron; G Ovlaque; A Capron
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

10.  Rapid and sensitive viral culture method for human immunodeficiency virus type 1.

Authors:  J B Jackson; R W Coombs; K Sannerud; F S Rhame; H H Balfour
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

View more
  7 in total

1.  Secretion of Toxoplasma gondii-specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis.

Authors:  J P Vendrell; F Pratlong; A Decoster; P Boulot; A M Conge; F Darcy; M Segondy; M F Huguet; A Serre
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Authors:  S Rusconi; A Riva; L Meroni; G Zehender; F Cocchi; L Scapellato; M Galli
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 3.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

4.  Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.

Authors:  H Pollack; M X Zhan; T Ilmet-Moore; K Ajuang-Simbiri; K Krasinski; W Borkowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 5.  Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants.

Authors:  A V Sison; J M Campos
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

6.  In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans.

Authors:  J P Vendrell; A M Conge; M Segondy; S Lombroso; M F Huguet; A Bertrand; F Janbon; A Serre
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

7.  Hepatitis C virus (HCV)-specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV RNA in HCV antibody-positive patients.

Authors:  J Ducos; A M Bianchi-Mondain; M Francois; M Boisset; J P Vendrell; F Barin; A Serre; D Larrey
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.